Renaissance Capital logo

Aratana Therapeutics Priced, Nasdaq: PETX

Developing medications for cats and dogs based on therapies for humans.

Industry: Health Care

First Day Return: +37.7%

Developing medications for cats and dogs based on therapies for humans.

Aratana Therapeutics (PETX) Performance

Created with Highcharts 10.3.2Chart context menuPETX vs. IPO Index (IPOUSA)2014201520162017201820192020202120222023202420250%+ 200%+ 400%-200%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index